This article offers a risk management standpoint on environmental services as a mission-critical function of any health care organization.

Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains.

Drug shortages are persistent and serious in the US, affecting care quality and costs. An early warning system could help.

COVID-19 exposed vulnerabilities of US routine and emergency medicine and critical equipment supply chains that introduced urgent need for change.

The WHO has a list of essential medicines. What about medicines that might not get to patients who need them on time?

International medicine importation raises ethics and safety questions that should be considered when weighing affordability against risk of harm.

Reliable supply of quality-assured medicines is hard to maintain in refugee camps in low- and middle-income countries with conflict zones.

Little attention has been given to roles played by human trafficking in health care organizations’ supply chains of key equipment, such as hand sanitizers and gloves.

Antimicrobial resistance is a looming pandemic, and poor health outcomes will not be borne equitably.

Antibiotics can be compared to other forms of “tragedy of the commons,” whereby a common good (effective treatment of infections) is jeopardized by individual consumption and lack of stewardship.